Couverture de eClinicalMedicine in conversation with

eClinicalMedicine in conversation with

eClinicalMedicine in conversation with

De : The Lancet Group
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

Editors at eClinicalMedicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from maternal health in the perinatal period and beyond to access to cancer care for people experiencing homelessness, the impact of weight bias in health care to oral treatments for MRSA skin infections, and more.

© 2026 The Lancet Group Hygiène et vie saine Maladie et pathologies physiques Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Mahdi Sheikh on pharmaceutical opioid use and subsequent cancer risk

      Mahdi Sheikh on pharmaceutical opioid use and subsequent cancer risk
      Dec 1 2025

      Mahdi Sheikh joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that regular use of pharmaceutical opioids for pain management may be associated with a higher risk of developing certain cancers, particularly those already known to be linked to opium consumption.


      Read the full article: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00371-2/fulltext

      Continue this conversation on social!
      Follow us today at...
      https://thelancet.bsky.social/
      https://instagram.com/thelancetgroup
      https://facebook.com/thelancetmedicaljournal
      https://linkedIn.com/company/the-lancet
      https://youtube.com/thelancettv
      Afficher plus Afficher moins
      22 min
    • Giulia Zamagni on the disease burden estimates and temporal trends from 1990 to 2023 for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy

      Giulia Zamagni on the disease burden estimates and temporal trends from 1990 to 2023 for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy
      Oct 13 2025

      Giulia Zamagni joins Claudia Schaefer to discuss her recent Series of 4 papers from the Italian Global Burden of Disease collaborators providing the disease burden estimates and temporal trends for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy.

      Click here to read the full text in this series: paper 1; paper 2; paper 3; paper 4


      Continue this conversation on social!
      Follow us today at...
      https://thelancet.bsky.social/
      https://instagram.com/thelancetgroup
      https://facebook.com/thelancetmedicaljournal
      https://linkedIn.com/company/the-lancet
      https://youtube.com/thelancettv
      Afficher plus Afficher moins
      21 min
    • Karin Modig and Yuge Zhang on longevity and health

      Karin Modig and Yuge Zhang on longevity and health
      Sep 17 2025

      Karin Modig and Yuge Zhang join Charlotte Rowbottom to discuss their recent work on the disease trajectories of centenarians in Sweden, covering disease burden, the rate of disease accumulation, and patterns of multimorbidity.

      Read the full article:

      https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00328-1/fulltext?dgcid=buzzsprout_icw_podcast_September_25_eclinm

      Continue this conversation on social!
      Follow us today at...
      https://thelancet.bsky.social/
      https://instagram.com/thelancetgroup
      https://facebook.com/thelancetmedicaljournal
      https://linkedIn.com/company/the-lancet
      https://youtube.com/thelancettv
      Afficher plus Afficher moins
      24 min
    Aucun commentaire pour le moment